Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.

Authors:
Noll A; Myers C; Biery MC; Meechan M; Tahiri S and 16 more

Journal:
Neoplasia

Publication Year: 2023

DOI:
10.1016/j.neo.2023.100921

PMCID:
PMC10465940

PMID:
37603953

Journal Information

Full Title: Neoplasia

Abbreviation: Neoplasia

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Evidence found in paper:

"Funding We are grateful for generous support from The Andrew McDonough B+ Foundation, The Avery Huffman DIPG Foundation, Kristie and Joe Berg, Erin Cordry and Eric Hanson, Freckles from Heaven, the Julianna Sayler Foundation, The Kellen Joyce Heart of a Warrior Research Fund, Liv Like a Unicorn, Hope for Harlee Foundation, Live Gray's Way, Love for Lucy, the McKenna Claire Foundation, the Pediatric Brain Tumor Research Fund Guild of Seattle Children's, the Run of Hope Seattle, Sam Day Foundation, Starbucks, the Seattle Sounders, Team Beans Infant Brain Tumor Fund, Team Cozzi Foundation, Tommy Strong Foundation, and Unravel Pediatric Cancer, and We Love You Connie Foundation. Funding is also provided 10.13039/100000098NIH grant R01CA114567 (J.M.O); Cookies for Kid's Cancer Young Investigator Grant (N.A.V.); DIPG All-In (N.A.V.); Matthew Larson Research Grant (N.A.V.); St. Baldrick's Stand Up to Cancer Dream Team Translational Cancer Research Grants (SU2C-AACR-DT-27-17 (N.A.V.), Stand Up to Cancer is a division of the Entertainment Industry Foundation and research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025